Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Return on Capital Employed (2024 - 2026)

Cannabis Bioscience International Holdings' Return on Capital Employed history spans 3 years, with the latest figure at 33.03% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 41.0% to 33.03% in Q1 2026 year-over-year; TTM through Feb 2026 was 33.03%, a 41.0% decrease, with the full-year FY2025 number at 46.74%, down 1171.0% from a year prior.
  • Return on Capital Employed hit 33.03% in Q1 2026 for Cannabis Bioscience International Holdings, down from 38.98% in the prior quarter.
  • Over the last five years, Return on Capital Employed for CBIH hit a ceiling of 100.43% in Q1 2024 and a floor of 33.03% in Q1 2026.
  • Historically, Return on Capital Employed has averaged 48.7% across 3 years, with a median of 41.68% in 2024.
  • Biggest five-year swings in Return on Capital Employed: crashed -6699bps in 2025 and later crashed -41bps in 2026.
  • Tracing CBIH's Return on Capital Employed over 3 years: stood at 41.68% in 2024, then dropped by -6bps to 38.98% in 2025, then fell by -15bps to 33.03% in 2026.
  • Business Quant data shows Return on Capital Employed for CBIH at 33.03% in Q1 2026, 38.98% in Q4 2025, and 40.25% in Q3 2025.